Drug recall · May 31, 2017
Benzonatate capsules recall
Why: Failed Stability Specifications: Out of Specification results obtained for preservative Methylparaben content.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Benzonatate capsules, 200 mg, 100-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bangaluru -560076 India, Distributed by Strides Pharma Inc East Brunswick, NJ 08816, NDC 64380-713-06
- Lots / codes
Lot #: 7225075, 7225076, 7225077, 7225078, 7225079, 7225080 Exp 7/2017; 7225180, 7225181, 7225322, 7225323, Exp 8/2017; 7225649A, 7225650A , 7225651A , 7225652A, 7225653A, 7225654A, Exp 9/2017
- Quantity
- 127,517 bottles
- Company
- Strides Pharma INC, East Brunswick, NJ
- Distribution
- U.S.A. Nationwide
- Initiated
- May 9, 2017 · Voluntary: Firm initiated
- Classified
- May 23, 2017
- Reported
- May 31, 2017
- Ended
- December 22, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Benzonatate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.